BioSpace News Archive

Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields

Novocure (NASDAQ: NVCR) today announced 19 presentations on Tumor Treating Fields (TTFields) will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2022, to be held in New Orleans from April 8 to April 13, 2022.

April 8, 2022
·
7 min read
Business

Orthofix Announces New Business Unit President

Orthofix Medical Inc today announced a leadership transition for its Orthopedics Business Unit. Kimberley Elting, currently Chief Legal and Development Officer for Orthofix, will become the President of the Global Orthopedics Business.

April 8, 2022
·
5 min read
Genetown

BeiGene to Present Clinical Results and Biomarker Data on Tislelizumab in Solid Tumors at the AACR Annual Meeting 2022

BeiGene today announced that clinical results, as well as biomarker data, from its immuno-oncology program in solid tumors will be presented at the American Academy for Cancer Research (AACR) Annual Meeting 2022.

April 8, 2022
·
9 min read
Bio NC

Pathalys Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference

Pathalys Pharma, Inc. today announced that the company will participate in the 21st Annual Needham Virtual Healthcare Conference.

April 8, 2022
·
1 min read
BioCapital

Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders

Diffusion Pharmaceuticals Inc. today announced a postponement of its Special Meeting of Stockholders.

April 8, 2022
·
4 min read
Business

Cytokinetics Announces Changes to Board of Directors

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced changes to its Board of Directors. L. Patrick Gage, Ph.D., Chairman of the Board of Directors since March 2010, will resign from the Board effective April 8, 2022.

April 8, 2022
·
5 min read
Biotech Bay

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Apr 08, 2022

Rigel Pharmaceuticals, Inc. reported the grant of stock options to purchase an aggregate of 626,000 shares of common stock to 15 newly hired employees.

April 8, 2022
·
3 min read
Deals

Lyra Therapeutics Announces $100.5 Million Private Placement

Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced that it has entered into a securities purchase agreement to sell securities in a private placement that is expected to result in gross proceeds of approximately $100.5 million, before deducting offering expenses.

April 8, 2022
·
3 min read
Business

Biofrontera Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Business Update

Biofrontera Inc. today announced financial results for the three and 12 months ended December 31, 2021, and provided a business update.

April 8, 2022
·
12 min read
Genetown

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 08, 2022

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the Company granted nonstatutory stock options to new employees as inducement awards outside of the Company’s 2019 Stock Incentive Plan.

April 8, 2022
·
1 min read